Publications Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling August 5, 2020 Madison, RW, Schrock, AB, Castellanos, EH, Gregg, JP, Snider, J, Ali, SM, Miller, VA, Singal, G, Alexander, BM, Venstrom, JM, Chung, JH. Lung Cancer. . https://doi.org/10.1016/j.lungcan.2020.07.033 Authors:Madison, RW, Schrock, AB, Castellanos, EH, Gregg, JP, Snider, J, Ali, SM, Miller, VA, Singal, G, Alexander, BM, Venstrom, JM, Chung, JH Sources:Lung Cancer Read the research SharePosted inLung cancerTreatment and Testing patterns More publicationsOctober 2026Treatment patterns and survival outcomes in a real-world cohort of lutetium 177 vipivotide tetraxetan-experienced patients with metastatic castration-resistant prostate cancerMay 2026Comparison of real-world overall survival between atezolizumab- and durvalumab-containing first- line induction and maintenance regimens in extensive-stage small cell lung cancerMay 2026Drivers of organotropism and patterns of metastatic progression in metastatic non-small cell lung cancer
October 2026Treatment patterns and survival outcomes in a real-world cohort of lutetium 177 vipivotide tetraxetan-experienced patients with metastatic castration-resistant prostate cancer
May 2026Comparison of real-world overall survival between atezolizumab- and durvalumab-containing first- line induction and maintenance regimens in extensive-stage small cell lung cancer
May 2026Drivers of organotropism and patterns of metastatic progression in metastatic non-small cell lung cancer